DRUG · Mapped RxNorm record
Raltegravir
Normalized identity: raltegravirView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
NCT01828073
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Infectionsunresolved
Interventions
RaltegravirDRUG · verified · RxNorm: raltegravir
Sponsors & collaborators
Mapped research locations
Los AngelesCalifornia, United States2The BronxNew York, United States2Rio de JaneiroBrazil2BostonMassachusetts, United States1BaltimoreMaryland, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1JacksonvilleFlorida, United States1La JollaCalifornia, United States1MemphisTennessee, United States1Long BeachCalifornia, United States1São PauloBrazil1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01828073 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.